EarningsBXPHARMA
BXPHARMA Earnings Update
Announcement summary
- What happened
- BXPHARMA published a corporate disclosure on 14 November 2019. Read the full announcement for details.
- Company
- Beximco Pharmaceuticals PLC.
- Announcement published
Original announcement
(Q1 Un-audited): Consolidated EPS was Tk. 2.13 for July-September 2019 as against Tk. 1.86 for July-September 2018; Consolidated NOCFPS was Tk. 4.59 for July-September 2019 as against Tk. 1.05 for July-September 2018. NAV per share was Tk. 75.09 as on September 30, 2019 and Tk. 68.59 as on September 30, 2018.
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aceb25a6b000040058481
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from BXPHARMA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.